Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?

B Liu, M Li, Z Zhou, X Guan, Y **ang - Journal of autoimmunity, 2020 - Elsevier
The emergent outbreak of coronavirus disease 2019 (COVID-19) has caused a global
pandemic. Acute respiratory distress syndrome (ARDS) and multiorgan dysfunction are …

cytokine storm syndrome: looking toward the precision medicine era.

EM Behrens, GA Koretzky - Arthritis & rheumatology, 2017 - search.ebscohost.com
The article focuses on cytokine storm syndrome which is a diverse set of conditions unified
by a clinical phenotype of systemic inflammation, multi-organ failure and hyperferritinemia …

Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome

L Fardet, L Galicier, O Lambotte, C Marzac… - Arthritis & …, 2014 - Wiley Online Library
Objective Because it has no unique clinical, biologic, or histologic features, reactive
hemophagocytic syndrome may be difficult to distinguish from other diseases such as …

Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of …

F Minoia, S Davì, AC Horne, E Demirkaya… - Arthritis & …, 2014 - Wiley Online Library
Objective To describe the clinical, laboratory, and histopathologic features, current
treatment, and outcome of patients with macrophage activation syndrome (MAS) …

[HTML][HTML] 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the …

S Ringold, PF Weiss, T Beukelman… - Arthritis and …, 2013 - ncbi.nlm.nih.gov
Guidelines and recommendations developed and/or endorsed by the American College of
Rheumatology (ACR) are intended to provide guidance for particular patterns of practice …

Macrophage activation syndrome and secondary hemophagocytic lymphohistiocytosis in childhood inflammatory disorders: diagnosis and management

LA Henderson, RQ Cron - Pediatric Drugs, 2020 - Springer
Macrophage activation syndrome (MAS), a form of secondary hemophagocytic
lymphohistiocytosis, is a frequently fatal complication of a variety of pediatric inflammatory …

Macrophage polarization and plasticity in systemic lupus erythematosus

MM Ahamada, Y Jia, X Wu - Frontiers in immunology, 2021 - frontiersin.org
Systemic lupus erythematosus (SLE) is an autoimmune disease that attacks almost every
organ. The condition mostly happens to adults but is also found in children, and the latter …

European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative

N Groot, N De Graeff, T Avcin… - Annals of the …, 2017 - ard.bmj.com
Childhood-onset systemic lupus erythematosus (cSLE) is a rare, multisystem and potentially
life-threatening autoimmune disorder with significant associated morbidity. Evidence-based …

[PDF][PDF] Haemophagocytic syndrome in rheumatic patients. A systematic review.

M Atteritano, A David, G Bagnato… - European Review for …, 2012 - researchgate.net
Rheumatic diseases are frequent chronic conditions that impose a great burden to society in
terms of losses in quality of life and cumbersome dependency1. Although they are …

Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg

C Crayne, RQ Cron - European journal of rheumatology, 2019 - pmc.ncbi.nlm.nih.gov
Macrophage activation syndrome (MAS) is the name given to secondary hemophagocytic
lymphohistiocytosis (sHLH) associated with rheumatic diseases. Previously, MAS has been …